skip navigation nih record
Vol. LXII, No. 23
November 12, 2010
cover

previous story



Volunteers

The phone numbers for more information about the studies below are 1-866-444-2214 (TTY 1-866-411-1010) unless otherwise noted.

Plaque Regression

If you have narrowing of the arteries and are taking statin medication, you may be eligible to participate in a study that will investigate if using magnetic resonance imaging is an effective method of measuring plaque in comparison to other methods available to estimate your risk of heart disease and stroke. All participants will come to the Clinical Center and receive statin medication or be willing to modify their current dose. The study will last approximately 24 months. All study-related tests and medications will be provided at no cost. Participants must be 55 years of age or older. Refer to study 10-CC-0214. Se habla espaņol.

Non-Invasive Imaging: Healthy Volunteers

If you are a healthy volunteer and have not been diagnosed with heart failure or ailments, you may be eligible to participate in a study that will evaluate the accuracy of non-invasive imaging testing in assessing how the heart functions. Study participants will be required to travel to NIH for initial screening and will undergo an MRI or CT scan with iodine contrast. The study duration is approximately 24 months. All study-related tests and medications will be provided at no cost. Refer to study 10-CC-0153. Se habla espaņol.

Non-Invasive Imaging: Patients

If you have been diagnosed with heart failure and you are not claustrophobic, you may be eligible to participate in a study that will evaluate the accuracy of non-invasive imaging testing in assessing how the heart functions. Study participants will be required to travel to NIH for initial screening and will undergo an MRI or CT scan with iodine contrast. The study duration is approximately 24 months. All study-related tests and medications will be provided at no cost. Refer to study 10-CC-0153. Se habla espaņol.

Asthma Study for Adults, 18-65

You may be eligible to participate in a clinical research study with the drug DAS 181. The investigational drug is currently being studied as a potential treatment for the flu. The goal of the study is to determine if DAS 181 can safely be given to individuals with well-controlled asthma. The study will last between 6-12 weeks and there are a total of 12 visits required. In order to participate, you must have had well-controlled asthma for at least the past 3 months, not be allergic to milk or milk products and not be taking oral corticosteroids. Compensation is provided. Refer to study 10-I-0085.

Bronchiectasis Study for Adults, 18-65

You may be eligible to participate in a clinical research study with the drug DAS 181. The investigational drug is currently being studied as a potential treatment for the flu. The goal of the study is to determine if DAS 181 can safely be given to individuals with bronchiectasis. The study will last between 6-12 weeks and there are a total of 12 visits required. In order to participate, you must have had a chest CT within the last 12 months that establishes a diagnosis, not be allergic to milk or milk products and not be taking corticosteroids. Compensation is provided. Refer to study 10-I-0085.


back to top of page